After weeks of speculation, former Celgene CEO Bob Hugin is confirming that he’s left Big Pharma to enter politics: He's announcing his candidacy for the U.S. Senate Tuesday. But the prospect of a pharma veteran running for Congress has been met with a mix of optimism and scorn.Original Article
You may also like
FDA Approves SpringWorks Therapeutics Treatment for...
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT:...
Axplora Announces €50 Million Investment in GLP-1...
Drug Digest: Advances in Small-Molecule Manufacturing
Navigating Drug Development: The Critical Role of...
MMS Acquires Exploristics and Its Flagship Modeling...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.